Contemporary concepts of inflammation, damage and repair in rheumatic diseases

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 5, 2006, Pages 829-848

  Luyten, Frank P ^a   Lories, Rik J U ^a   Verschueren, Patrick ^a   de Vlam, Kurt ^a   Westhovens, René ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

destructive mechanisms; disease remission; joint homeostasis; remodelling; tissue repair

Indexed keywords

BLOCKING ANTIBODY; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; CYTOKINE RECEPTOR; GROWTH DIFFERENTIATION FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 10; LIPOXIN; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; OSTEOPROTEGERIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSIS; ARTICULAR CARTILAGE; CALCIFICATION; CHRONIC ARTHRITIS; DISEASE COURSE; HOMEOSTASIS; HUMAN; INFLAMMATION; JOINT DESTRUCTION; JOINT FUNCTION; MOLECULAR INTERACTION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; REVIEW; RHEUMATIC DISEASE; TISSUE INJURY; TISSUE REPAIR; VALIDATION PROCESS;

ANIMALS; ARTHRITIS; BIOMECHANICS; BONE REMODELING; CARTILAGE, ARTICULAR; CHRONIC DISEASE; HOMEOSTASIS; HUMANS; INFLAMMATION; OSTEOCLASTS; OSTEOGENESIS; RHEUMATIC DISEASES; SYNOVIAL MEMBRANE; TISSUE ENGINEERING;

EID: 33748505885     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.06.009     Document Type: Review

References (113)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 6937 (2003) 356-361
2. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 3 (1996) 307-310
3. Feldmann M., Brennan F.M., Williams R.O., et al. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Practice & Research in Clinical Rheumatology 18 1 (2004) 59-80
4. Braun J., and Sieper J. Biological therapies in the spondyloarthritides - the current state. Rheumatology 43 9 (2004) 1072-1084
5. Lories R.J., and Luyten F.P. Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. Clinical Rheumatology 20 1 (2001) 3-9
6. Lories R.J., and Luyten F.P. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine and Growth Factor Reviews 16 3 (2005) 287-298
7. Rau R., Herborn G., and Wassenberg S. Healing of erosive changes in rheumatoid arthritis. Clinical and Experimental Rheumatology 22 5 (2004) S44-S49
8. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 24 2 (2003) 218-235
9. Lafyatis R., Remmers E.F., Roberts A.B., et al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-ß and retinoids. Journal of Clinical Investigation 83 4 (1989) 1267-1276
10. De Bari C., Dell'Accio F., Tylzanowski P., and Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism 44 8 (2001) 1928-1942
11. Edwards J.C. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Research 2 5 (2000) 344-347
12. Valencia X., Higgins J.M., Kiener H.P., et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. Journal of Experimental Medicine 200 12 (2004) 1673-1679
13. Lee D., Kien H.P., Agarwal S., et al. Synovial cadherin-11. Arthritis Research and Therapy 6 supplement 3 (2004) 96
14. Kawaguchi J., Kii I., Sugiyama Y., et al. The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. Journal of Bone and Mineral Research 16 2 (2001) 260-269
15. Hadeball B., Borchers A., and Wedlich D. Xenopus cadherin-11 (Xcadherin-11) expression requires the Wg/Wnt signal. Mechanisms of Development 72 1-2 (1998) 101-113
16. Ahmed N., Sammons J., Carson R.J., et al. Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow. Cell Biology International 25 5 (2001) 429-435
17. Scharstuhl A., Vitters E.L., van der Kraan P.M., and van Den Berg W.B. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor ß/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis and Rheumatism 48 12 (2003) 3442-3451
18. Simkin P.A. The musculoskeletal system: A. Joints. In: Klippel J.H., Weyand C.M., and Wortmann R.L. (Eds). Primer on the Rheumatic Diseases (1997), Arthritis Foundation, Atlanta 10-14
19. Rhee D.K., Marcelino J., Baker M.A., et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. Journal of Clinical Investigation 115 3 (2005) 622-631
20. Dell'Accio F., De Bari C., and Luyten F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis and Rheumatism 44 7 (2001) 1608-1619
21. Serra R., Johnson M., Filvaroff E.H., et al. Expression of a truncated, kinase-defective TGF-ß type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. Journal of Cell Biology 139 2 (1997) 541-552
22. Rountree R.B., Schoor M., Chen H., et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biology 2 11 (2004) e355
23. Luyten F.P., Dell'Accio F., and De Bari C. Skeletal tissue engineering: opportunities and challenges. Best Practice & Research Clinical Rheumatology 15 5 (2001) 759-769
24. Luyten F.P., Lories R.J., De Bari C., et al. Bone morphogenetic proteins and the synovial joint. In: Vukicevic S., and Sampath K.T. (Eds). Progress in Inflammation Research (2004), Springer Verlag, Berlin 243-248
25. Erlacher L., Ng C.K., Ullrich R., et al. Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis and Rheumatism 41 2 (1998) 263-273
26. Tardif G., Hum D., Pelletier J.P., et al. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis and Rheumatism 50 8 (2004) 2521-2530
27. Chubinskaya S., Merrihew C., Cs-Szabo G., et al. Human articular chondrocytes express osteogenic protein-1. Journal of Histochemistry and Cytochemistry 48 2 (2000) 239-250
28. Fukui N., Zhu Y., Maloney W.J., et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. Journal of Bone and Joint Surgery. American Volume 85A (2003) 59-66
29. Seto H., Kamekura S., Miura T., et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. Journal of Clinical Investigation 113 5 (2004) 718-726
30. Benjamin M., and McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. Journal of Anatomy 199 Pt 5 (2001) 503-526
31. Lories R.J.U., Derese I., and Luyten F.P. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. Journal of Clinical Investigation 115 6 (2005) 1571-1579
32. Zvaifler N.J., and Firestein G.S. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis and Rheumatism 37 6 (1994) 783-789
33. Muller-Ladner U., Kriegsmann J., Franklin B.N., et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. American Journal of Pathology 149 5 (1996) 1607-1615
34. Pap T., Muller-Ladner U., Gay R.E., and Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Research 2 5 (2000) 361-367
35. Pap T., Aupperle K.R., Gay S., et al. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis and Rheumatism 44 3 (2001) 676-681
36. Firestein G.S., Echeverri F., Yeo M., et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proceedings of the National Academy of Sciences of the United States of America 94 20 (1997) 10895-10900
37. Yamanishi Y., Boyle D.L., Pinkoski M.J., et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. American Journal of Pathology 160 1 (2002) 123-130
38. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis?. Arthritis and Rheumatism 33 6 (1990) 768-773
39. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis?: II. T cell- independent mechanisms from beginning to end. Arthritis and Rheumatism 46 2 (2002) 298-308
40. Corr M., and Zvaifler N.J. Mesenchymal precursor cells. Annals of the Rheumatic Diseases 61 1 (2002) 3-5
41. Buckley C.D., Filer A., Haworth O., et al. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Annals of the Rheumatic Diseases 63 supplement 2 (2004) ii92-ii95
42. Parsonage G., Filer A.D., Haworth O., et al. A stromal address code defined by fibroblasts. Trends in Immunology 26 3 (2005) 150-156
43. Luyten F.P. Mesenchymal stem cells in arthritis. In: Panayi G.S., Firestein G.S., and Wollheim F.A. (Eds). Rheumatoid Arthritis: Frontiers in Pathophysiology and Treatment (2006), Oxford University Press, Oxford pp. 551-559.
44. Goldring S.R. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42 supplement 2 (2003) ii11-ii16
45. Walsh N.C., Crotti T.N., Goldring S.R., and Gravallese E.M. Rheumatic diseases: the effects of inflammation on bone. Immunological Reviews 208 (2005) 228-251
46. Lipsky P.E. Integrating biologic therapy into the comprehensive care of patients with rheumatoid arthritis. Journal of Rheumatology. Supplement 72 (2005) 54-57
47. Miossec P. Interleukin-17 in rheumatoid arthritis - if T cells were to contribute to inflammation and destruction through synergy. Arthritis and Rheumatism 48 3 (2003) 594-601
48. Lubberts E., Koenders M.I., and van Den Berg W.B. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Research and Therapy 7 1 (2004) 29-37
49. Gravallese E.M., Manning C., Tsay A., et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis and Rheumatism 43 2 (2000) 250-258
50. Haynes D.R., Crotti T.N., Loric M., et al. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40 6 (2001) 623-630
51. Haynes D.R., Barg E., Crotti T.N., et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford) 42 1 (2003) 123-134
52. Crotti T.N., Smith M.D., Weedon H., et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Annals of the Rheumatic Diseases 61 12 (2002) 1047-1054
53. Gravallese E.M., Harada Y., Wang J.T., et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. American Journal of Pathology 152 4 (1998) 943-951
54. Pettit A.R., Ji H., von Stechow D., et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. American Journal of Pathology 159 5 (2001) 1689-1699
55. Kong Y.Y., Feige U., Sarosi I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 6759 (1999) 304-309
56. Redlich K., Hayer S., Maier A., et al. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis and Rheumatism 46 3 (2002) 785-792
57. Romas E., Sims N.A., Hards D.K., et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. American Journal of Pathology 161 4 (2002) 1419-1427
58. Jimenez-Boj E., Redlich K., Turk B., et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. Journal of Immunology 175 4 (2005) 2579-2588
59. Gortz B., Hayer S., Redlich K., et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. Journal of Bone and Mineral Research 19 6 (2004) 990-998
60. Wu Y., Liu J., Feng X., et al. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis. Arthritis and Rheumatism 52 10 (2005) 3257-3268
61. van Den Berg W.B., and Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I. Best Practice & Research Clinical Rheumatology 13 4 (1999) 577-597
62. Mengshol J.A., Vincenti M.P., Coon C.I., et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappa B - Differential regulation of collagenase 1 and collagenase 3. Arthritis and Rheumatism 43 4 (2000) 801-811
63. Burrage P.S., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Frontiers in Bioscience 11 (2006) 529-543
64. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322 6079 (1986) 547-549
65. Henderson B., and Pettipher E.R. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clinical and Experimental Immunology 75 2 (1989) 306-310
66. Seckinger P., Yaron I., Meyer F.A., et al. Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6. Arthritis and Rheumatism 33 12 (1990) 1807-1814
67. Kane D., Jensen L.E., Grehan S., et al. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. Journal of Rheumatology 31 7 (2004) 1274-1280
68. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nature Immunology 6 12 (2005) 1191-1197
69. Han J.H., and Ulevitch R.J. Limiting inflammatory responses during activation of innate immunity. Nature Immunology 6 12 (2005) 1198-1205
70. Goronzy J.J., and Weyand C.M. T-cell regulation in rheumatoid arthritis. Current Opinion in Rheumatology 16 3 (2004) 212-217
71. Shukunami C., Oshima Y., and Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochemical and Biophysical Research Communications 333 2 (2005) 299-307
72. Hayami T., Funaki H., Yaoeda K., et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. Journal of Rheumatology 30 10 (2003) 2207-2217
73. François R.J., Gardner D.L., Degrave E.J., and Bywaters E.G. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis and Rheumatism 43 9 (2000) 2011-2024
74. Ho A.M., Johnson M.D., and Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289 5477 (2000) 265-270
75. Johnson K., Polewski M., van Etten D., and Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arteriosclerosis Thrombosis and Vascular Biology 25 4 (2005) 686-691
76. Williams C.J., Zhang Y., Timms A., et al. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. American Journal of Human Genetics 71 4 (2002) 985-991
77. Espinoza L.R., Espinoza C.G., Cuellar M.L., et al. Fibroblast function in psoriatic-arthritis. 2. Increased expression of ß-platelet-derived growth-factor receptors and increased production of growth-factor and cytokines. Journal of Rheumatology 21 8 (1994) 1507-1511
78. Espinoza L.R., Aguilar J.L., Espinoza C.G., et al. Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses. Journal of Rheumatology 21 8 (1994) 1502-1506
79. Reece R.J., Canete J.D., Parsons W.J., et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis and Rheumatism 42 7 (1999) 1481-1484
80. Buckley C.D., Pilling D., Lord J.M., et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends in Immunology 22 4 (2001) 199-204
81. Ory P.A., Gladman D.D., and Mease P.J. Psoriatic arthritis and imaging. Annals of the Rheumatic Diseases 64 (2005) 55-57
82. Grisar J., Bernecker P.M., Aringer M., et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. Journal of Rheumatology 29 7 (2002) 1430-1436
83. Cotten A., Flipo R.M., Mentre A., et al. Sapho syndrome. Radiographics 15 5 (1995) 1147-1154
84. Helliwell P.S., Hickling P., and Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?. Annals of the Rheumatic Diseases 57 3 (1998) 135-140
85. Maric I., Poljak L., Zoricic S., et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. Journal of Cellular Physiology 196 2 (2003) 258-264
86. Dodds R.A., Merry K., Littlewood A., and Gowen M. Expression of messenger-RNA for Il1-ß, Il6 and Tgf-ß-1 in developing human bone and cartilage. Journal of Histochemistry and Cytochemistry 42 6 (1994) 733-744
87. Braun J., Bollow M., Neure L., et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis and Rheumatism 38 4 (1995) 499-505
88. Tanno M., Furukawa K.I., Ueyama K., et al. Uniaxial cyclic stretch induces osteogenic differentiation and synthesis of bone morphogenetic proteins of spinal ligament cells derived from patients with ossification of the posterior longitudinal ligaments. Bone 33 4 (2003) 475-484
89. Nakamura I., Ikegawa S., Okawa A., et al. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Human Genetics 104 6 (1999) 492-497
90. Boers M., Brooks P., Simon L.S., et al. OMERACT: an international initiative to improve outcome measurement in rheumatology. Clinical and Experimental Rheumatology 23 5 (2005) S10-S13
91. Fransen J., Speyer I., Moens H.B., and van Riel P.L.C.M. The effectiveness of systematic monitoring of RA disease activity in daily practice (TRAC): a multicentre cluster-RCT. Annals of the Rheumatic Diseases 63 (2004) 84
92. van Riel P.L.C.M., and Fransen J. To be in remission or not: is that the question?. Annals of the Rheumatic Diseases 64 10 (2005) 1389-1390
93. Pando J.A., Duray P., Yarboro C., et al. Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis. Journal of Rheumatology 27 8 (2000) 1848-1854
94. Smolen J.S., Han C., Bala M., et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement - a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis and Rheumatism 52 4 (2005) 1020-1030
95. Rau R., Sander O., and Wassenberg S. Erosion healing in rheumatoid arthritis after anakinra treatment. Annals of the Rheumatic Diseases 62 7 (2003) 671-673
96. Sharp J.T., van der Heijde D., Boers M., et al. Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT subcommittee on healing of erosions. Journal of Rheumatology 30 5 (2003) 1102-1107
97. van der Heijde D., and Landewe R. Imaging: do erosions heal?. Annals of the Rheumatic Diseases 62 (2005) ii10-ii12
98. Vukicevic S., Basic V., Rogic D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. Journal of Clinical Investigation 102 1 (1998) 202-214
99. Zeisberg M., Hanai J., Sugimoto H., et al. BMP-7 counteracts TGF-ß 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine 9 7 (2003) 964-968
100. Cho H.J., Kim H.S., Lee M.M., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108 23 (2003) 2918-2925
101. Rabelink T.J., de Boer H.C., de Koning E.J.P., and van Zonneveld A.J. Endothelial progenitor cells: more than an inflammatory response?. Arteriosclerosis Thrombosis and Vascular Biology 24 5 (2004) 834-838
102. Marinova-Mutafchieva L., Taylor P., Funa K., et al. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis and Rheumatism 43 9 (2000) 2046-2055
103. Marinova-Mutafchieva L., Williams R.O., Funa K., et al. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis and Rheumatism 46 2 (2002) 507-513
104. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. International Journal of Biochemistry and Cell Biology 36 4 (2004) 568-584
105. Jorgensen C., Gordeladze J., and Noel D. Tissue engineering through autologous mesenchymal stem cells. Current Opinion in Biotechnology 15 5 (2004) 406-410
106. Baksh D., Song L., and Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine 8 3 (2004) 301-316
107. Luyten F.P. Mesenchymal stem cells in osteoarthritis. Current Opinion in Rheumatology 16 5 (2004) 599-603
108. Brittberg M., Lindahl A., Nilsson A., et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England Journal of Medicine 331 14 (1994) 889-895
109. Peterson L., Minas T., Brittberg M., et al. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clinical Orthopaedics and Related Research 374 (2000) 212-234
110. Brittberg M., Tallheden T., Sjogren-Jansson E., et al. Autologous chondrocytes used for articular cartilage repair - an update. Clinical Orthopaedics and Related Research 391 (2001) S337-S348
111. Bentley G., Biant L.C., Carrington R.W.J., et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. Journal of Bone and Joint Surgery. British Volume 85B 2 (2003) 223-230
112. Knutsen G., Engebretsen L., Ludvigsen T.C., et al. Autologous chondrocyte implantation compared with microfracture in the knee - a randomized trial. Journal of Bone and Joint Surgery. American Volume 86A 3 (2004) 455-464
113. Murphy J.M., Fink D.J., Hunziker E.B., and Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis and Rheumatism 48 12 (2003) 3464-3474